Your browser doesn't support javascript.
loading
Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.
Samuels, Aaron M; Ansong, Daniel; Kariuki, Simon K; Adjei, Samuel; Bollaerts, Anne; Ockenhouse, Christian; Westercamp, Nelli; Lee, Cynthia K; Schuerman, Lode; Bii, Dennis K; Osei-Tutu, Lawrence; Oneko, Martina; Lievens, Marc; Attobrah Sarfo, Maame Anima; Atieno, Cecilia; Morelle, Danielle; Bakari, Ashura; Sang, Tony; Jongert, Erik; Kotoh-Mortty, Maame Fremah; Otieno, Kephas; Roman, François; Buabeng, Patrick Boakye Yiadom; Ntiamoah, Yaw; Ofori-Anyinam, Opokua; Agbenyega, Tsiri.
Afiliación
  • Samuels AM; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, United States Centers for Disease Control and Prevention, Kisumu, Kenya; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA
  • Ansong D; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Kariuki SK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Adjei S; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Bollaerts A; GSK, Wavre, Belgium.
  • Ockenhouse C; PATH's Malaria Vaccine Initiative, Washington, DC, USA.
  • Westercamp N; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Lee CK; PATH's Malaria Vaccine Initiative, Washington, DC, USA.
  • Schuerman L; GSK, Wavre, Belgium.
  • Bii DK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Osei-Tutu L; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Oneko M; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Lievens M; GSK, Wavre, Belgium.
  • Attobrah Sarfo MA; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Atieno C; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Morelle D; GSK, Wavre, Belgium.
  • Bakari A; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Sang T; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Jongert E; GSK, Wavre, Belgium.
  • Kotoh-Mortty MF; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Otieno K; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Roman F; GSK, Wavre, Belgium.
  • Buabeng PBY; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Ntiamoah Y; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Ofori-Anyinam O; GSK, Wavre, Belgium.
  • Agbenyega T; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
Lancet Infect Dis ; 22(9): 1329-1342, 2022 09.
Article en En | MEDLINE | ID: mdl-35753316
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Antirrábicas / Malaria Falciparum / Vacunas contra la Malaria / Malaria Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Child / Humans País/Región como asunto: Africa Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Gabón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Antirrábicas / Malaria Falciparum / Vacunas contra la Malaria / Malaria Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Child / Humans País/Región como asunto: Africa Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Gabón